Back to company

INBICON A/S: Financial statements 2016

CVR: 27036635

INBICON A/S (CVR 27036635) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -13,750,000 and a net result of DKK -16,756,000 compared with DKK -35,128,000 the year before. Equity amounted to DKK 47,130,000. The solvency ratio was 96.5%.

Gross Profit
-13,750,000 kr.
Profit/Loss
-16,756,000 kr.
Equity
47,130,000 kr.
Total Assets
48,832,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--13.8 mio.-16.8 mio.47.1 mio.-
2015--43.2 mio.-35.1 mio.63.9 mio.-
201414 mio.-61.4 mio.-45.4 mio.59 mio.-
201316.8 mio.-84 mio.-68.5 mio.44.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is INBICON A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

INBICON A/S: The 2015 annual report is outApr 19, 2016

INBICON A/S has published its annual report for 2015. Gross profit came to DKK -43,216,000, and the net result was DKK -35,128,000.

About INBICON A/S

INBICON A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2003. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. The company has 0 employees. In 2025, the company reported revenue of DKK 0 and a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity amounted to DKK 35,752,000.